Clinical Trials Browser

Phase EARLY_PHASE1 × Terminated × ibrutinib × Clear all

NCT02966730 2025-05-13

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

Phase EARLY_PHASE1 Terminated

Lymphoma, Follicular